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P rimary Sjögren’s syndrome (SS) is an autoim-mune disease that generally affects the exocrine 
glands of middle-aged women.  Fifteen percent of cases 
of SS are associated with systemic severe extraglandular 
complications such as synovitis,  neuropathy,  leukocy-
topenia,  cutaneous vasculitis,  and non-Hodgkin’s lym-
phoma [1].  Roughly 82% of the pleural effusions in SS 
are exudative and must be considered as a potential 
cause of effusion,  including infections,  malignancies,  
systemic diseases,  and autoimmune pleuritis [2].  
Rheumatoid arthritis (RA) and systemic lupus erythe-
matosus (SLE) are the most common forms of autoim-
mune pleuritis,  but primary SS rarely causes pleural 
effusion [3 , 4].  We report the case of a 70-year-old man 
with primary SS initially presenting as pleuritis.
Case Presentation
A 70-year-old Japanese man consulted our hospital 
for a month-long history of fever and anterior chest 
pain,  exacerbated by breathing.  His medical history 
was unremarkable but he had smoked 20 cigarettes daily 
for 51 years.  He denied any family history of autoim-
mune diseases.
His vital signs on admission were as follows: blood 
pressure,  110/70 mmHg; pulse rate,  93 beats/min;  
respiratory rate,  20/min; and axillary body tempera-
ture,  38.1°C.  The physical examination revealed dull-
ness on chest percussion of the patient’s back at the 
bottom of the lungs.  He denied a history of dry mouth 
but had multiple caries in the mouth.  Conjunctival 
hyperemia and dryness were not observed.  The labora-
tory examinations showed leukopenia and elevated 
C-reactive protein (CRP) levels (Table 1).  Chest X-ray 
and computed tomography (CT) showed pleural effu-
sions at the right and left-anterior thoracic cavities 
(Fig. 1).  An additional laboratory examination revealed 
positive homogenous antinuclear antibody (ANA) and 
anti SS-A and SS-B antibodies (Table 1).  Thoracentesis 
suggested aseptic exudative pleural effusion without 
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malignant cells (Table 2).
Although Schirmer’s test was negative (right eye 
6 mm/5 min,  left eye 11 mm/5 min),  lymphocyte infil-
tration around the salivary gland ducts was observed on 
lip biopsy.  Intravenous antibiotics could not relieve the 
patient’s fever.  Using the serological and biopsy find-
ings,  we made the diagnosis of primary SS accompa-
nied by pleuritis based on the classification criteria for 
primary SS [5].  Although the patient was positive for 
rheumatoid factor,  there were no RA-like symptoms,  
and there were no serological characteristics of SLE,  
scleroderma,  polymyositis,  dermatomyositis,  or mixed 
connective tissue disease; there was little reason to sus-
pect secondary SS.  After initiating oral prednisolone 
40 mg per day,  the prolonged fever promptly subsided 
and the pleural effusion disappeared (Fig. 2).  The pred-
nisolone dosage was gradually tapered at 17.5 mg per 
day on 105 days after the initiation,  which is the day on 
which we planned to reduce the dose by following the 
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Fig.  1　 Chest X-ray (A) and CT (B ,C,  arrowheads) showing pleural effusions at the right-side and left-anterior thoracic cavities.
Table 1　 Laboratory Data on Admission
WBC (/uL) 2390 TP (g/dL) 6 Na (mmol/L) 138 ANA 320 (homo)
Lym (%) 15.4 Alb (g/dL) 2.3 K (mmol/L) 3.9 RF (U/mL) 155.3
Neu (%) 74.2 AST (U/L) 54 Cl (mmol/L) 104 Anti-RNPantibody (- )
Mon (%) 10 ALT (U/L) 52 CRP (mg/dL) 5.1 Anti-Sm antibody (- )
Eos (%) 0.2 ALP (U/L) 240 PCT (ng/mL) 0.137 Anti-ds-DNA antibody (- )
Bas (%) 0.1 LD (U/L) 302 Ferritin (ng/mL) 614 Anti-SS-A antibody (U/mL) >240
RBC (106/uL) 3.51 G-GT (U/L) 40 IgG (mg/dL) 1469.7 Anti-SS-B antibody (U/mL) 12.9
Hb (g/dL) 10.7 T.Bil (mg/dL) 0.39 IgA (mg/dL) 332.7 Anti-Scl-70 antibody (- )
MCV (fL) 97.5 UN (mg/dL) 18.5 IgM (mg/dL) 68.5 Anti-Jo-1 antibody (- )
MCHC (g/dL) 31.2 Cr (mg/dL) 0.89 C3 (mg/dL) 97.6 Anti-centromere antibody (- )
Plt (104/uL) 31.5 CK (U/L) 86 C4 (mg/dL) 21.9 Anti-cardiolipin antibody (- )
PR3-ANCA (- )
MPO-ANCA (- )
WBC,  white blood cell; Lym,  lymphocyte; Neu,  neutrophil; Mon,  monocyte; Eos,  eosinophil; Bas,  basophil; RBC,  red blood cell;  
Hb,  hemoglobin; MCV,  mean corpuscular volume; MCHC,  mean corpuscular hemoglobin concentration; Plt,  platelet; TP,  total protein;  
Alb,  albumin; AST,  aspartate aminotransferase; ALT,  alanine aminotransferase; ALP,  alkaline phosphatase; LD,  lactate dehydroge-
nase; G-GT,  gamma-glutamyl transpeptidase; T-Bil,  total bilirubin; UN,  nrea nitrogen; Cr,  creatinine; CK,  creatine kinese; Na,  sodium;  
K,  potassium; Cl,  chloride; CRP,  c-reactive protein; PCT,  procalcotonin; IgG,  immunoglobulin G; IgA,  immunoglobulin A; IgM,  immu-
noglobulin M; C3,  complemen 3; C4,  complemen 4; ANA,  antinuclear antibody; homo,  homogenous pattern; RF,  rheumatoid factor;  
PR3-ANCA,  proteinase-3 antineutrophil cytoplasmic antibody; MPO-ANCA,  myeloperoxidase antineutrophil cytoplasmic antibody
Table 2　 Analysis of pleural effusion
Cell count (/μL) 2000
mononuclear cells (%) 20
multinuclear cells (%) 80
TP (g/dL) 3.3
LD (U/L) 477
Malignant cells (- )
Bacteria culture (- )
ADA (- )
TP,  total protein; Alb,  albumin; LD,  lactate dehydrogenase;  
ADA,  adenosine deaminase.
patient’s clinical course.
Discussion
We report the details of the case of a 70-year-old 
male with primary SS complicated with pleuritis.  
Sjögren’s syndrome is a systemic autoimmune disorder 
which occurs nine times more frequently in women 
than men [6 , 7].  Primary SS is defined as SS that occurs 
without accompanying collagen diseases such as SLE or 
RA [6 , 7].  Primary SS affects mainly exocrine glands 
such as the lacrimal and salivary glands,  and extraglan-
dular involvement is less frequently observed [1].  
Pleuritis is a rare complication with only 14 reported 
cases to date [8-21].  Among these,  eight (57.1%) 
patients presented with pleuritis as the initial manifes-
tation,  as did our patient.  For the remaining cases,  
pleuritis occurred after the patient was diagnosed with 
primary SS [8-21].
Of the nine patients with SS presenting with pleuritis 
as the initial manifestation (including our patient),  six 
are males over 60 years old (Table 3).  This is interesting 
because primary SS more frequently develops in mid-
dle-aged women.  It is known that male patients with 
primary SS are more likely to experience extraglandular 
systemic complications such as interstitial pneumonia 
and vasculitis [22 , 23].  The cases of male patients with 
other common autoimmune diseases such as SLE and 
RA have tended to be complicated with pleuritis more 
often compared to female patients [24 , 25].  To the best 
of our knowledge,  no previous reports have discussed a 
difference in the incidence of pleuritis between male and 
female patients with primary SS.
Male and elderly patients with primary SS are more 
likely to test negative for anti-SS-A/SS-B antibodies,  
ANA,  and rheumatoid factors [22 , 26].  However,  all 
nine of the patients mentioned above were positive for 
anti-SS-A antibodies and ANA.  Among patients with 
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Fig.  2　 Pleural effusion disappeared after the initiation of oral prednisolone on chest X-ray (A) and CT (B ,C).
Table 3　 Reported cases of pleuritis as an initial manifestation of primary Sjögrenʼs Syndrome
Case No. 









1. (8) 62,  male fever right ×4 ×8 ×40 591 (U/mL) (- )
2. (10) 70,  male ― left (+ ) (- ) ×1280 80.9 (U/mL) ―
3. (12) 73,  male dyspnea bilateral 25.9 (U/mL) 59.1 (U/mL) ×320 ×160 Nephrotic syndrome
4. (13) 65,  male cough,  dyspnea bilateral >500 (U/mL) 49 (U/mL) ×320 (- ) (- )
5. (14) 63,  male cough,  dyspnea,  chest pain bilateral ×256 (- ) ×320 15 (U/mL) (- )
6. (7) 40,  female fever bilateral ×64 ×8 ×80 (- ) (- )
7. (15) 58,  female dyspnea bilateral (+ ) (- ) ×1280 ― (- )
8. (17) 42,  female chest tightness bilateral ×320 ×320 (+ ) ― (- )
This case 70,  male chest pain,  fever bilateral >240 (U/mL) 12.9 (U/mL) ×320 155.3 (U/mL) (- )
ANA,  antinuclear antibody; RF,  rheumatoid factor.
RA and SLE,  high titers of autoantibodies were associ-
ated with the complication of pleuritis [27 , 28].  Thus,  
elevated serum levels of autoantibodies may suggest the 
occurrence of pleuritis.  Further studies are required to 
test this possibility.
In conclusion,  we have reported the case of an 
elderly man who initially presented prolonged chest 
pain and was finally diagnosed with primary 
SS-associated pleuritis.  Unlike typical cases of primary 
SS,  pleuritis possibly be the associated complication of 
primary SS among elderly male patients.  Physicians 
should consider primary SS as a differential diagnosis of 
prolonged fever accompanying chest pain.
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